版本:
中国

BRIEF-Abeona receives regulatory approval to start clinical trial in Australia

May 9 Abeona Therapeutics Inc:

* Abeona Therapeutics receives regulatory approval to initiate clinical trial in Australia with ABO-102 gene therapy for patients with MPS IIIA

* Abeona Therapeutics receives regulatory approval to initiate clinical trial in Australia with ABO-102 gene therapy for patients with MPS IIIA

* Clinical study was approved by Australian government department of health therapeutic goods administration Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐